Placebo Groupe
News Placebo
MediciNova asthma drug fails trial; shares crashReutersMediciNova, which is testing MN-221 as a treatment for acute asthma attacks not responsive to standard therapy, said the drug failed to show a statistically significant improvement over a placebo. MN-221 looks to treat the condition by bypassing ...MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma ...FierceBiotechMediciNova study doesn't yield significant resultsMarketWatchMediciNova Misses Primary Goal in Mid-Stage Trial of IV Asthma DrugXconomyall 28 news articles »
Biologic Works in Ulcerative ColitisMedPage TodayAt 6 weeks, 47.1% of patients receiving vedolizumab had achieved a clinical response, compared with 25.5% of those randomized to placebo (P<0.0001), said Brian G. Feagan, MD, of Robarts Research Institute in London, Ontario, in a late-breaker session ...Takeda drug impresses in ulcerative colitis studyReutersall 2 news articles »
MyFox PhiladelphiaNew Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ...MarketWatch (press release)[4] In the 24-week study, 226 patients were randomized (106 to linagliptin, and 120 to placebo)[1], and received at least one dose of the study drug in order to be included in the safety analyses.[1] Patients who had a measurement of A1C at baseline ...Lilly Optimistic on Type-2 Diabetes Drug for Black PatientsFox BusinessBoehringer Ingelheim announces diabetes trial dataMass High TechLilly, BI diabetes drug shows greater A1C reduction in African-American adults ...Drug Store NewsRTT Newsall 23 news articles »
Marijuana for MS: panacea or placebo ? Examiner.com This study attempted to clinically measure efficacy in a placebo -controlled trial. The lead author of the study, Jody Corey-Bloom, MD, PhD, from the University of San Diego says there is a trade-off. Both spasticity and pain were reduced in the ...
Marijuana for MS: panacea or placebo?Examiner.comThis study attempted to clinically measure efficacy in a placebo-controlled trial. The lead author of the study, Jody Corey-Bloom, MD, PhD, from the University of San Diego says there is a trade-off. Both spasticity and pain were reduced in the ...
Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo ...Chiropractic EconomicsA randomised, single-blind, placebo-controlled study was conducted to evaluate the efficacy of low-energy laser therapy in 40 female patients with fibromyalgia. Patients with fibromyalgia were randomly allocated to active (Ga-As) laser or placebo laser ...
Colitis Responds to Anti-TNF TherapyMedPage TodaySAN DIEGO -- Patients with ulcerative colitis treated with golimumab, a tumor necrosis factor (TNF) inhibitor, had robust clinical responses compared with placebo, researchers reported here. At week six of treatment, clinical responses were seen in ...J&J's Simponi Helps Colitis Patients In Clinical TrialWall Street JournalPatients with ulcerative colitis respond to Simponi, study findsDrug Store NewsNew Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ...PR Newswire (press release)Zenopaall 11 news articles »
Aspirin Found To Prevent Recurrent Venous ThromboembolismForbesFollowing 6 to 18 months of oral anticoagulation, 403 patients with first-time unprovoked VTE were randomized to aspirin (100 mg daily) or placebo for two years. Aspirin therapy resulted in a significant reduction in VTE but did not cause an increase ...Aspirin May Reduce Risk of Repeat Blood ClotsWebMDall 2 news articles »
Soy supplement shows no blood pressure benefit Reuters 'DISAPPOINTING' RESULTS So for their study, Wong and his colleagues randomly assigned 24 menopausal women to take either soy isoflavones or placebo tablets for six weeks. The supplement gave a daily dose of 80 milligrams of isoflavones. and more »
Soy supplement shows no blood pressure benefitReuters'DISAPPOINTING' RESULTS So for their study, Wong and his colleagues randomly assigned 24 menopausal women to take either soy isoflavones or placebo tablets for six weeks. The supplement gave a daily dose of 80 milligrams of isoflavones.and more »
Topical Drug May Hit the Spot for Female Arousal MedPage Today Symptoms of female sexual arousal disorder (FSAD) improved significantly during treatment with a topical prostaglandin (alprostadil) compared with placebo . Note that younger women (<45) treated with the highest concentration of the medication had the ...
Topical Drug May Hit the Spot for Female ArousalMedPage TodaySymptoms of female sexual arousal disorder (FSAD) improved significantly during treatment with a topical prostaglandin (alprostadil) compared with placebo. Note that younger women (<45) treated with the highest concentration of the medication had the ...
Shire Presents Data on VenvanseZacks.comIn this phase III double-blind, placebo-controlled, randomized study, long-term maintenance of efficacy and safety of Venvanse in children and adolescents aged 6 to 17 years with moderately symptomatic ADHD was evaluated. Significantly less treatment ...Efficacy of Shire's Vyvanse maintained in ADHD adolescents after at least six ...The Pharma Letterall 4 news articles »
Lilly's GLP-1 Agonist DeliversZacks.comResults from the phase II, randomized, double-blind, placebo-controlled, 26-week, parallel study showed that dulaglutide achieved non-inferiority after 16 weeks for mean 24-hour systolic blood pressure (SBP). Two doses (0.75 mg and 1.5 mg) of ...Lilly Diabetes Presents Phase II Blood Pressure?Pharmaceutical ProcessingEli Lilly's diabetes drug meets mid-stage trial goalReutersDulaglutide passes BP hurdle, but heart-rate increase observedTheHeart.OrgWall Street Journalall 33 news articles »
Aspirin Cuts Recurrent VTE After Stopping WarfarinMedPage TodayThis study found a marked reduction in recurrent venous thromboembolism among patients with unprovoked events who were randomly assigned to either aspirin (100 mg daily) or placebo and were followed for 2 years. Aspirin reduced recurrent venous ...Aspirin May Prevent Recurrence of Deep Vein Blood ClotsU.S. News & World ReportAspirin Effective in Preventing Thromboembolism RecurrenceDoctors Loungeall 11 news articles »
Zee NewsVitamin C can help pregnant smokersWBRCResearchers found that newborns of smoking women who took a Vitamin C supplement had better lung function compared with newborns of smoking women who received a placebo. Most health advice has us feeling guilty over our indulgences.For pregnant smokers who can't quit, an Oregon study tests vitamin COregonLive.comBabies of smoking moms get help from vitamin CJakarta PostPregnant smokers should take vitamin CABC2 NewsEmpowHer -Medical Xpressall 26 news articles »
Antibiotic Cuts Flare-Ups in Bronchiectasis MedPage Today A small randomized trial found that low-dose erythromycin significantly decreased exacerbations compared to placebo in patients with bronchiectasis not caused by cystic fibrosis. Note that oral streptococci increased in resistance to macrolides in the ...
Antibiotic Cuts Flare-Ups in BronchiectasisMedPage TodayA small randomized trial found that low-dose erythromycin significantly decreased exacerbations compared to placebo in patients with bronchiectasis not caused by cystic fibrosis. Note that oral streptococci increased in resistance to macrolides in the ...
Data for Amarin's AMR101 to be Presented at the National Lipid Association ...MarketWatch (press release)The second poster is titled "A Phase 3, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 12-Week Study to Evaluate the Effect of Two Doses of AMR101 on Fasting Serum Triglycerides and Other Lipid Parameters in Statin-Treated Patients with ...and more »
Voice of AmericaClinical Trials for Alzheimer's Disease Preventative Drug to Begin Early 2013Santa Barbara IndependentThe study involves testing candidates for the genetic mutation, taking a record of baseline conditions, administering either the medication or a placebo over a period of time, and monitoring the subjects' progress. In this double-blind trial, ...A Campaign Against Alzheimer's DiseaseVoice of AmericaU.S. Government Sets Out Alzheimer's PlanScientific Americanall 3 news articles »
Takeda drug impresses in ulcerative colitis studyChicago TribuneThe biologic drug, vedolizumab, met the goals of the Phase III trial with highly statistically significant advantages in rates of remission, clinical response and bowel healing compared with a placebo, researchers said. Of the patients taking part in ...Vedolizumab Scores on Safety, Efficacy for Ulcerative ColitisFamily Practice News Digital Networkall 7 news articles »
PR WebSteroids Help Unfreeze Bell's PalsyMedPage TodayThey ranged in age from 18 to 75 and were enrolled at 17 public referral centers involved in the Swedish and Finnish Scandinavian Bell's Palsy Study, a prospective, randomized, double-blind, placebo-controlled, multicenter trial.'Prednisolone's Considerable Effect On Bells Palsy Symptoms'Medical News TodayNew Study Reports Prednisolone Significantly Reduces Lasting Effects of Bell's ...PR Web (press release)all 4 news articles »
Lilly's GLP-1 Agonist DeliversDaily MarketsResults from the phase II, randomized, double-blind, placebo-controlled, 26-week, parallel study showed that dulaglutide achieved non-inferiority after 16 weeks for mean 24-hour systolic blood pressure (SBP). Two doses (0.75 mg and 1.5 mg) of ...Lilly posts clean safety data on PhIII diabetes blockbuster hopefulFierceBiotechall 4 news articles »
Novartis lung drug superior to placebo over 1 yearChicago TribuneZURICH (Reuters) - A Novartis experimental lung drug to treat smokers' cough was superior to a placebo in improving lung function over a one-year period and had similar efficacy to a rival drug from Pfizer and Boehringer Ingelheim, the Swiss drugmaker ...Novartis NVA237 Phase III data showed rapid, sustained improvement in lung ...ReutersNVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International ...MarketWatch (press release)New Novartis COPD drug beats placebo over a yearPharma TimesPMLiVEall 35 news articles »
Page: 1/5
Next Page (2/5) Sonneries Gsm Ringtones
[ Back to Celebrities Index | Post Comment ]